UPC Analytics
DEEN
Übersicht · Eingereicht: 23. Okt. 2023

UPC_CFI_376/2023

DEVICE FOR TREATING NIGHT TIME BREATHING PROBLEMS

VerletzungHauptverletzungsklageBrussels LDInfringementCase Closed
Parteien

Kläger

  • Name not displayed for GDPR reasons. Represented by Christophe RONSE
Vertreter: C. Ronse; K. Claeyé; M.w. Rijsdijk; D.e. Colenbrander

Beklagte

  • OrthoApnea S.L.
  • Vivisol B BV
Vertreter: Van den Horst; Niemeijer
Richter
  • Samuel Granata
  • Andras Kupecz
  • Margot Kokke
Patente
  • EP2331036
  • [Anonymized patent number]
CPC-Codes: A61F5/566

Technologiebereich: Medical Devices · Implants

Sektor: Pharmaceutical & Medical

Ausgang
Nicht verletztNicht verletzt
Eingereicht: 23. Okt. 2023
Erste Entscheidung:
Sprache: Dutch

Decision on the merits by the Brussels Local Division (full panel) in an infringement action concerning a patent on a medical device (sleep apnea treatment). The court dismissed both the literal infringement claim and the infringement-by-equivalence claim against OrthoApnea S.L. and Vivisol B BV. On literal infringement, the court interpreted the patent claims in light of the claim as a whole and found the accused products did not meet all claim features. On equivalence, the court found no functional equivalence regardless of which equivalence test was applied. The court also lifted the earlier evidence-preservation order (seizure) and ordered the claimant (unnamed, anonymized) to pay the defendants' costs. A key procedural holding addressed the temporal conditions for bringing main proceedings following evidence preservation.

Im UPC-Register öffnen
Ansprüche
Streitigall
Nicht verletztall
Hinweise: Both literal and equivalence infringement claims dismissed against OrthoApnea and Vivisol; specific claim numbers not enumerated in excerpt.